Clinical Trials Logo

Clinical Trial Summary

Chronic liver diseases represent a major public health problem and are responsible for more than 150,000 deaths in Europe each year. These diseases are accompanied by symptoms that profoundly alter the quality of life and mainly affect people of working age, leading to a major economic impact. Coagulation disorders, inflammation and vascular alterations are associated with chronic liver diseases but their role in the onset and/or progression of liver diseases is still not fully understood. A better understanding of chronic liver diseases and in particular of the factors that play a role in the onset and progression of these diseases would improve patient management and therefore have a positive impact on individuals, but also on the healthcare system and the economy.


Clinical Trial Description

Chronic liver diseases represent a major public health problem and are responsible for more than 150,000 deaths in Europe each year. These diseases are accompanied by symptoms that profoundly alter the quality of life and mainly affect people of working age, leading to a major economic impact. Coagulation disorders, inflammation and vascular alterations are associated with chronic liver diseases but their role in the onset and/or progression of liver diseases is still not fully understood. A better understanding of chronic liver diseases and in particular of the factors that play a role in the onset and progression of these diseases would improve patient management and therefore have a positive impact on individuals, but also on the healthcare system and the economy. The main objective is to identify the role of coagulation in the development and progression of chronic liver diseases and their complications. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05865691
Study type Observational
Source Assistance Publique - Hôpitaux de Paris
Contact Pierre Emmanuel Rautou
Phone 140875283
Email pierre-emmanuel.rautou@aphp.fr
Status Not yet recruiting
Phase
Start date May 9, 2023
Completion date December 31, 2035

See also
  Status Clinical Trial Phase
Completed NCT03255187 - Effect of Dietary Supplemental Fish Oil in Alleviating Health Hazards Associated With Air Pollution N/A
Completed NCT02239744 - Intervention Study on the Health Impact of Air Filters in Chinese Adults N/A
Completed NCT00143715 - Oral Vitamin K for Warfarin Associated Coagulopathy Phase 3
Completed NCT00794755 - Low Dose Supplementation to Improve Anticoagulation Control With Oral Vitamin K as an Adjuvant to Warfarin Therapy Phase 3
Enrolling by invitation NCT06415760 - Reference Range Study for the Quantra System With the QStat Cartridge in Obstetric Patients
Recruiting NCT04377490 - Thrombo Embolic Events in Hospitalized Patients With Covid-19 Serious Acute Pneumopathy
Recruiting NCT04299828 - Evaluation of Pro-Inflammatory Leukocyte Activity in Patients Undergoing Cardiac Surgery
Withdrawn NCT01121510 - Hemostatic Closure of Femoral Artery Access Site, Using the QuickClose Design 9 System Phase 1/Phase 2
Completed NCT04746391 - Impact of Clotting on Dialyzer Efficiency N/A
Completed NCT03820401 - Dialysis Performance of Different Dialyzer Membranes Using Different Coagulation Strategies N/A
Completed NCT05998421 - The Effects of Acupuncture on the Natural Pregnancy in Patients With Recurrent Abortion N/A
Terminated NCT00909298 - Left Ventricular Assist Device (LVAD) Specialized Centers of Clinically Orientated Research (SCCOR) Coagulation - Acute Intrinsic Pathway Antagonist (IPA) Phase 2
Completed NCT02339415 - Targeted Anticoagulation Therapy to Reduce Inflammation and Cellular Activation in Long-term HIV Disease Phase 2
Terminated NCT01428102 - RapidTEG MA Validation N/A
Completed NCT00990158 - Does Low Dose Oral Vitamin K Improve International Normalized Ratio (INR) Stability? Phase 3
Completed NCT00705991 - Validation of Thrombelastometry (ROTEM®) Phase 4
Completed NCT05166824 - Clinical Study To Assess The Safety, Parameters And Efficacy For Procedures Using A Radiofrequency Device N/A
Completed NCT03418363 - How DHEA Supplements Affect Coagulation in Women Using Birth Control Pills Phase 4
Completed NCT03139097 - Reference Range Study for the Quantra Analyzer With the Quantra Surgical Cartridge
Recruiting NCT05853796 - Observational Dutch Young Symptomatic StrokE studY - nEXT